Pioglitazone and Metformin Hydrochloride Tablets recall: Subpotent
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro…
Why was Pioglitazone and Metformin Hydrochloride Tablets recalled?
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020
- Product
- Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro…
- Recalling firm
- Macleods Pharma Usa Inc
- Quantity
- 4694 30x60-count bottles
- Distribution
- Nationwide
- Recall date
- February 12, 2020
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)